Abstract
Lipid peroxidation has gained renewed attention with increasing evidence showing its biological role in producing toxic compounds and cellular signaling mediators. The assessment of lipid peroxidation levels in vivo is difficult partly because lipids are oxidized by different oxidants by different mechanisms to give versatile types of products, which may undergo metabolism and secondary reactions. In the present study, total hydroxyoctadecadienoic acids (tHODE) and 7α- and 7β-hydroxycholesterol (t7-OHCh) from 44 healthy human subjects were assessed as biomarkers after reduction with sodium borohydride followed by saponification with potassium hydroxide comparing with the prevailing standard 8-isoprostaglandin F2α (t8-iso-PGF2α). The average concentrations of tHODE, total 8-isoprostaglandin F2α (t8-iso-PGF2α), t7α-OHCh, and t7β-OHCh were 203, 0.727, 87.1, and 156 nmol/l plasma and 1,917, 12.8, 1,372, and 3,854 nmol/l packed erythrocytes, respectively. The ratios of tHODE and t7-OHCh to the parent substrates were 194 and 3,519 μmol tHODE/mol linoleates and 40.9 and 686 μmol t7-OHCh/mol cholesterol in plasma and erythrocytes, respectively. It was found that (1) t7-OHCh in blood was unexpectedly high, as high as or even higher than tHODE, (2) the amounts of tHODE was more than 100 fold higher than t8-iso-PGF2α (3) the level of lipid oxidation products in erythrocytes was higher than that in plasma, and (4) lipid peroxidation products level tended to increase while antioxidant level decrease with age. These products may be used as potential biomarker for assessment of lipid peroxidation and oxidative stress in vivo.
Similar content being viewed by others
Abbreviations
- BHT:
-
2, 6-Di-tert-butyl-4-methylphenol
- BOSS:
-
Biomarkers of oxidative stress study
- BSTFA:
-
N,O-Bis(trimethylsilyl)trifluoroacetamide
- CoQ10:
-
Coenzyme Q10 (ubiquinol-10 + ubiquinone-10);
- HV:
-
Hematocrit value
- 9-HODE-d4 :
-
9S-Hydroxy-10E, 12Z-octadecadienoic-9,10,12,13-d4 acid
- HPODE:
-
Hydroperoxyoctadecadienoic acid
- t8-iso-PGF2α :
-
Total 8-iso-prostaglandin F2α
- 8-iso-PGF2α-d4 :
-
8-Iso-prostaglandin F2α-d4;
- 7-KCh:
-
7-Ketocholesterol
- LDL:
-
Low density lipoprotein
- PBS:
-
Phosphate-buffered saline
- SeP:
-
Selenoprotein P
- tCh:
-
Total cholesterol
- 7-OOHCh:
-
7-Hydroperoxycholesterol
- t7-OHCh:
-
Total 7-hydroxycholesterol
- t18:2:
-
Total linoleate
- tHODE:
-
Total hydroxyoctadecadienoic acid
- Q10H2 :
-
Ubiquinol-10
- Q10 :
-
Ubiquinone-10
- αT:
-
α-Tocopherol
- ZE/EE :
-
Stereoisomer ratio of HODE (9- and 13-(Z,E)-HODE/9- and 13-(E,E)-HODE)
References
Niki E, Yoshida Y, Saito Y, Noguchi N (2005) Lipid peroxidation: mechanisms, inhibition, and biological effects. Biochem Biophys Res Commun 338:668–676
Leonarduzzi G, Arkan MC, Basaga H, Chiarpotto E, Sevanian A, Poli G (2000) Lipid oxidation products in cell signaling. Free Rad Biol Med 28:1370–1378
Ceaser EK, Moellering DR, Shiva S, Ramachandran A, Landar A, Venkartraman A, Crawford J, Patel R, Dickinson DA, Ulasova E, Ji S, Darley-Usmar VM (2004) Mechanisms of signal transduction mediated by oxidized lipids: the role of the electrophile-responsive proteome. Biochem Soc Trans 32:151–155
Chen ZH, Saito Y, Yoshida Y, Sekine A, Noguchi N, Niki E (2005) 4-Hydroxynonenal induces adaptive response and enhances PC12 celltolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J Biol Chem 51:41921–41927
Chen ZH, Yoshida Y, Saito Y, Sekine A, Noguchi N, Niki E (2006) Induction of adaptive response and enhancement of PC12 cell tolerance by 7-hydroxycholesterol and 15-deoxy-delta-prostaglandin J2 through up-regulation of cellular glutathione by different mechanisms. J Biol Chem 281:14440–14445
Gao L, Wang J, Sekhar KR, Yin H, Yared NF, Schneider SN, Sasi S, Dalton TP, Anderson ME, Chan JY, Morrow JD, Freeman ML (2007) Novel N-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between keap1 and cullin3. J Biol Chem 282:2529–2537
Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ II (1990) A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87:9383–9387
Musiek ES, Yin H, Milne GL, Morrow JD (2005) Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Lipids 40:987–994
Yoshida Y, Niki E (2004) Detection of lipid peroxidation in vivo: total hydroxyoctadecadienoic acid and 7-hydroxycholesterol as oxidative stress marker. Free Rad Res 38:787–794
Porter NA, Caldwell SE, Mills KA (1995) Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30:277–290
Pikuleva IA (2006) Cholesterol-metabolizing cytochromes P450. Drug Metab Dispos 34:513–520
Smith LL, Johnson BH (1989) Biological activies of oxysterols. Free Rad Biol Med 7:285–332
Saito Y, Watanabe Y, Saito E, Honjoh T, Takahashi K (2001) Production and application of monoclonal antibodies to human selenoprotein P. J Health Sci 47:346–352
Barclay LRC, Vinqvist MR, Antunes F, Pinto RE (1997) Antioxidant activity of vitamin E determined in a phospholipid membrane by product studies: avoiding chain transfer reactions by vitamin E radicals. J Am Chem Soc 119:5764–5765
Noguchi N, Numano R, Kaneda H, Niki E (1998) Oxidation of lipids in low density lipoprotein particles. Free Rad Res 29:43–52
Sevanian A, Seraglia R, Traldi P, Rossato P, Ursini F, Hodis H (1994) Analysis of plasma cholesterol oxidation products using gas- and high-performance liquid chromatography/mass spectrometry. Free Rad Biol Med 17:397–409
Brown AJ, Jessup W (1999) Oxysterols and atherosclerosis. Atherosclerosis 142:1–28
Diczfalusy U (2004) Analysis of cholesterol oxidation products in biological samples. J AOAC Int 87:467–473
BjÖkhem I, Reihner E, Angelin B, Ewerth S, Akerlund JE, Einarsson K (1987) On the possible use of the serum level of 7α-hydroxycholesterol as a marker for increased activity of the cholesterol 7α-hydroxylase in humans. J Lipid Res 28:889–894
Schweizer RA, Zurcher M, Balazs Z, Dick B, Odermatt A (2004) Rapid hepatic metabolism of 7-ketocholesterol by 11 beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzyme. J Biol Chem 279:18415–18424
Hult M, Elleby B, Shafqat N, Svensson S, Rane A, Jornvall H, Abrahmsen L, Oppermann U (2004) Human and rodent type 11 beta-hydroxysteroid dehydrogenases are 7beta-hydroxycholesterol dehydrogenases involved in oxysterol metabolism. Cell Mol Life Sci 61:992–999
Arampatzis S, Kadereit B, Schuster D, Balazs Z, Schweizer RA, Frey FJ, Langer T, Odermatt A (2005) Comparative enzymology of 11 beta-hydroxysteroid dehydrogenase type 1 from six species. J Mol Endocrinol 35:89–101
Thomas JP, Maiorino M, Ursini F, Girotti AW (1990) Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation. In situ reduction of phospholipid and cholesterol hydroperoxides. J Biol Chem 265:454–461
Kühn H, Borchert A (2002) Regulation of enzymatic lipid peroxidation: the interplay of peroxidation and peroxide reducing enzymes. Free Rad Biol Med 33:154–172
Kühn H, Heydeck D, Hugou I, Gniwotta C (1997) In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J Clin Invest 99:888–893
Yamashita H, Nakamura A, Noguchi N, Niki E, Kühn H (1999) Oxidation of low density lipoprotein and plasma by 15-lipoxygenase and free radicals. FEBS Lett 445:287–290
Dufour C, Loonis M (2005) Regio- and stereoselective oxidation of linoleic acid bound to serum albumin: identification by ESI-mass spectrometry and NMR of the oxidation products. Chem Phys Lipids 138:60–68
Niki E, Yamamoto Y, Takahashi M, Yamamoto K, Yamamoto Y, Komuro E, Miki M, Yasuda H, Mino M (1988) Free-radical mediated damage of blood and its inhibition by antioxidants. J Nutr Sci Vitaminol 34:507–512
Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brod N, FitzGerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts II LJ, Rokach J, Shigenaga MK, Sohal RS, Sun J, Tice RR, Van Thiel DH, Wellner D, Walter PB, Tomer KB, Mason RP, Barrett JC (2005) Biomarkers of oxidative stress study II. Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Rad Biol Med 38:698–710
Kadiiska MB, Gladen BC, Baird DD, Graham LB, Parker CE, Ames BN, Basu S, FitzGerald GA, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts II LJ, Rokach J, Shigenaga MK, Sun J, Walter PB, Tomer KB, Barrett JC, Mason RP (2005) Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Rad Biol Med 38:711–718
Yoshida Y, Itoh N, Hayakawa M, Piga R, Cynshi O, Jishage K, Niki E (2005) Lipid peroxidation induced by carbon tetrachloride and its inhibition by antioxidant as evaluated by an oxidative stress marker, HODE. Toxicol Appl Pharmacol 208:87–97
Yoshida Y, Itoh N, Hayakawa M, Habuchi Y, Inoue R, Chen ZH, Cao J, Cynshi O, Niki E (2006) Lipid peroxidation in mice fed choline-deficient diet and its inhibition by antioxidants as evaluated by an oxidative stress marker, HODE. Nutrition 22:303–311
Tanito M, Yoshida Y, Kaidzu S, Ohira A, Niki E (2006) Detection of lipid peroxidation in light-exposed mouse retina assessed by oxidative stress markers, total hydroxyoctadecadienoic acid and 8-iso-prostaglandin F2α. Neurosci Lett 398:63–68
Yoshida Y, Hayakawa M, Niki E (2005) Total hydroxyoctadecadienoic acid as a marker for lipid peroxidation in vivo. BioFactors 24:7–15
Yoshida Y, Hayakawa M, Habuchi Y, Niki E (2006) Evaluation of the dietary effects of coenzyme Q in vivo by the oxidative stress marker, hydroxyoctadecadienoic acid and its stereoisomer ratio. Biochim Biophys Acta 1760:1558–1568
Kitano S, Yoshida Y, Kawano K, Hibi N, Niki E (2007) Oxidative status of human low density lipoprotein isolated by anion-exchange high-performance liquid chromatography—assessment by total hydroxyoctadecadienoic acid, 7-hydroxycholesterol, and 8-iso-prostaglandin F2α. Anal Chim Acta 585:86–93
Kalen A, Appelkvist EL, Dallner G (1989) Age-related changes in the lipid compositions of rat and human tissues. Lipids 24:579–584
Komorowski J, Muratsu K, Nara Y, Willis R, Folkers K (1988) Significance of biological parameters of human blood levels of CoQ10. BioFactors 1:67–69
Zita C, Overvad K, Mortensen SA, Sindberg CD, Moesgaard S, Hunter DA (2003) Serum coenzyme Q10 concentrations in healthy men supplemented with 30 mg or 100 mg coenzyme Q10 for two months in a randomised controlled study. BioFactors 18:185–193
Miles MV, Horn PS, Morrison JA, Tang PH, DeGrauw T, Pesce AJ (2003) Plasma coenzyme Q10 reference intervals, but not redox status, are affected by gender and race in self-reported healthy adults. Clin Chim Acta 332:123–132
Kaikkonen J, Kosonen L, Nyyssonen K, Ristonmaa U, Salonen JT (1998) Effect of combined coenzyme Q10 and d-α-tocopheryl acetate supplementation on exercise-induced lipid peroxidation and muscular damage: a placebo-controlled double-blind study in marathon runners. Free Rad Res 29:85–92
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Yoshida, Y., Saito, Y., Hayakawa, M. et al. Levels of Lipid Peroxidation in Human Plasma and Erythrocytes: Comparison between Fatty Acids and Cholesterol. Lipids 42, 439–449 (2007). https://doi.org/10.1007/s11745-007-3037-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11745-007-3037-5